Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: From cultured cells to mouse heart

Endocrinology

Volumn 151, Issue 9, 2010, Pages 4467-4476

  Latouche, Celine ^a   Sainte Marie, Yannis ^a   Steenman, Marja ^b   Chaves, Paulo Castro ^a   Naray Fejes Toth, Aniko ^c   Fejes Toth, Geza ^c   Farman, Nicolette ^a   Jaisser, Frederic ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTICOSTERONE; DOXYCYCLINE; MINERALOCORTICOID RECEPTOR; SERINE PROTEINASE INHIBITOR;

ANIMAL; CELL LINE; CYTOLOGY; DNA MICROARRAY; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HEART MUSCLE; HEART MUSCLE CELL; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PREGNANCY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ALDOSTERONE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CORTICOSTERONE; DOXYCYCLINE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; RATS; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; SIGNAL TRANSDUCTION;

EID: 77956033682     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0237     Document Type: Article

References (48)

1. Young M, Funder JW 2000 Aldosterone and the heart. Trends Endocrinol Metab 11:224-226
2. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341:709-717
3. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309-1321
4. Fuller PJ, Young MJ 2005 Mechanisms of mineralocorticoid action. Hypertension 46:1227-1235
5. Farman N, Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280:F181-F192
6. Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombès M 2007 The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal 5:e012
7. Rusvai E, Náray-Fejes-Tóth A 1993 A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem 268:10717-10720
8. Lombès M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP 1995 Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase in the human heart. Circulation 92:175-182
9. 2+ current in mice. J Physiol 569:153-162
10. Rougier JS, Muller O, Berger S, Centeno G, Schütz G, Firsov D, Abriel H 2008 Mineralocorticoid receptor is essential for corticosteroid-induced up-regulation of L-type calcium currents in cultured neonatal cardiomyocytes. Pflugers Arch 456:407-412
11. Gómez AM, Rueda A, Sainte-Marie Y, Pereira L, Zissimopoulos S, Zhu X, Schaub R, Perrier E, Perrier R, Latouche C, Richard S, Picot MC, Jaisser F, Lai FA, Valdivia HH, Benitah JP 2009 Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins. Circulation 119:2179-2187
12. Ouvrard-Pascaud A, Sainte-Marie Y, Bénitah JP, Perrier R, Soukaseum C, Cat AN, Royer A, Le Quang K, Charpentier F, Demolombe S, Mechta-Grigoriou F, Beggah AT, Maison-Blanche P, Oblin ME, Delcayre C, Fishman GI, Farman N, Escoubet B, Jaisser F 2005 Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation 111:3025-3033
13. Sainte-Marie Y, Nguyen Dinh Cat A, Perrier R, Mangin L, Soukaseum C, Peuchmaur M, Tronche F, Farman N, Escoubet B, Benitah JP, Jaisser F 2007 Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block. FASEB J 21:3133-3141 (Pubitemid 47565533)
14. Turchin A, Guo CZ, Adler GK, Ricchiuti V, Kohane IS, Williams GH 2006 Effect of acute aldosterone administration on gene expression profile in the heart. Endocrinology 147:3183-3189 (Pubitemid 43901108)
15. Muller O, Pradervand S, Berger S, Centeno G, Milet A, Nicod P, Pedrazzini T, Tronche F, Schütz G, Chien K, Rossier BC, Firsov D 2007 Identification of corticosteroid-regulated genes in cardiomyocytes by serial analysis of gene expression. Genomics 89:370-377
16. Fejes-Tóth G, Náray-Fejes-Tóth A 2007 Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling? Endocrinology 148:1502-1510
17. Yoshikawa N, Nagasaki M, Sano M, Tokudome S, Ueno K, Shimizu N, Imoto S, Miyano S, Suematsu M, Fukuda K, Morimoto C, Tanaka H 2009 Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism. Am J Physiol 296:E1363-E1373
18. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Léger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S 2005 Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112:471-481
19. Lamirault G, Gaborit N, Le Meur N, Chevalier C, Lande G, Demolombe S, Escande D, Nattel S, Léger JJ, Steenman M 2006 Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. J Mol Cell Cardiol 40:173-184
20. Pisani DF, Coldefy AS, Elabd C, Cabane C, Salles J, Le Cunff M, Derijard B, Amri EZ, Dani C, Leger JJ, Dechesne CA 2007 Involvement of BTBD1 in mesenchymal differentiation. Exp Cell Res 313:2417-2426
21. Lamirault G, Le Meur N, Roussel JC, Le Cunff MF, Baron D, Bihouee A, Guisle I, Raharijaona M, Ramstein G, Teusan R, Chevalier C, Gueffet JP, Trochu JN, Leger JJ, Houlgatte R, Steenman M 9 September 2009 Molecular risk stratification in advanced heart failure patients. J Cell Mol Med 10.1111/j.1582-4934.2009.00913.x
22. Steenman M, Lamirault G, Le Meur N, Le Cunff M, Escande D, Léger JJ 2005 Distinct molecular portraits of human failing hearts identified by dedicated cDNA microarrays. Eur J Heart Fail 7:157-165 (Pubitemid 40215607)
23. Steenman M, Chen YW, Le Cunff M, Lamirault G, Varró A, Hoffman E, Léger JJ 2003 Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomics 12:97-112
24. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP 2002 Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30:e15
25. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, Saxild HH, Nielsen C, Brunak S, Knudsen S 2002 A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol 3:research0048
26. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
27. Smyth GK 2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:article3
28. Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, Kane DW, Reimers M, Stephens RM, Bryant D, Burt SK, Elnekave E, Hari DM, Wynn TA, Cunningham-Rundles C, Stewart DM, Nelson D, Weinstein JN 2005 High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 6:168
29. Couette B, Marsaud V, Baulieu EE, Richard-Foy H, Rafestin-Oblin ME 1992 Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter. Endocrinology 130:430-436
30. Silvestre JS, Robert V, Escoubet B, Heymes C, Oubénaïssa A, Desopper C, Swynghedauw B, Delcayre C 2000 Different regulation of cardiac and renal corticosteroid receptors in aldosterone-salt treated rats: effect of hypertensionandglucocorticoids. J Mol Cell Cardiol 32:1249-1263
31. Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H 2007 Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Hypertens Res 30:427-437
32. Ohtani T, Ohta M, Yamamoto K, Mano T, Sakata Y, Nishio M, Takeda Y, Yoshida J, Miwa T, Okamoto M, Masuyama T, Nonaka Y, Hori M 2007 Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: beneficial effects of mineralocorticoid receptor blocker. Am J Physiol Regul Integr Comp Physiol 292:R946-R954
33. Yoshida M, Ma J, Tomita T, Morikawa N, Tanaka N, Masamura K, Kawai Y, Miyamori I 2005 Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure. Congest Heart Fail 11:12-16
34. Muller OG, Parnova RG, Centeno G, Rossier BC, Firsov D, Horisberger JD 2003 Mineralocorticoid effects in the kidney: correlation between αENaC, GILZ, and Sgk-1mRNA expression and urinary excretion of Na+ and K+. J Am Soc Nephrol 14:1107-1115 (Pubitemid 36514653)
35. Náray-Fejes-Tóth A, Canessa C, Cleaveland ES, Aldrich G, Fejes-Tóth G 1999 sgk is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial na+ channels. J Biol Chem 274:16973-16978
36. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D 1999 Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 96:2514-2519
37. Tucker RP, Chiquet-Ehrismann R 2009 The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta 1793:888-892
38. Sakai T, Furukawa Y, Chiquet-Ehrismann R, Nakamura M, Kitagawa S, Ikemura T, Matsumoto K 1996 Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts. J Cell Sci 109(Pt 8):2069-2077
39. Riddle EL, Schwartzman RA, Bond M, Insel PA 2005 Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ Res 96:401-411
40. Deppe CE, Heering PJ, Viengchareun S, Grabensee B, Farman N, Lombès M 2002 Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology 143:1932-1941
41. Gerhardt S, Hassall G, Hawtin P, McCall E, Flavell L, Minshull C, Hargreaves D, Ting A, Pauptit RA, Parker AE, Abbott WM 2007 Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains. J Mol Biol 373:891-902
42. Nakamura K, Hirohata S, Murakami T, Miyoshi T, Demircan K, Oohashi T, Ogawa H, Koten K, Toeda K, Kusachi S, Ninomiya Y, Shiratori Y 2004 Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction. J Biochem 136:439-446
43. Lijnen HR 2005 Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 3:35-45
44. Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE 1998 Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 32:965-971
45. Gooptu B, Lomas DA 2009 Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu Rev Biochem 78:147-176
46. Asakura M, Kitakaze M 2009 Global gene expression profiling in the failing myocardium. Circ J 73:1568-1576
47. Pages G, Rouayrenc JF, Le Cam G, Mariller M, Le Cam A 1990 Molecular characterization of three rat liver serine-protease inhibitors affected by inflammation and hypophysectomy. Protein and mRNA analysis and cDNA cloning. Eur J Biochem 190:385-391 (Pubitemid 20201527)
48. Di Zhang A, Cat AN, Soukaseum C, Escoubet B, Cherfa A, Messaoudi S, Delcayre C, Samuel JL, Jaisser F 2008 Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling. Hypertension 52:1060-1067